Interventions for preventing oral complications in people receiving treatment for cancer
Interventions for preventing oral complications in people receiving treatment for cancer
Cochrane Review
7 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Incidence of VAP
placebo or usual care |
0.67 | - | - | Not assessed |
|
Mortality
placebo or usual care |
1.03 | - | - | Not assessed |
|
Duration of ventilation
placebo or usual care |
-1.1 | - | - | Not assessed |
|
Duration of ICU stay
placebo or usual care |
-0.89 | - | - | Not assessed |
|
Adverse effects
placebo or usual care |
nan | - | - | Not assessed |
|
VAP
Placebo or usual care |
0.6 | - | - | Not assessed |
|
Ventilator-associated pneumonia
placebo or usual care |
0.75 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD008367 |
| Outcomes: | 7 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
7